Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus is a research paper published in Diabetes Obesity and Metabolism (2022). On theSindex it has a DataRank of 1.8. It has been cited 45 times, with 32 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.574
From this paper's citation signal
Citation Network Contribution
1.2
From 30 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 32 citers.
NHLBI NIH HHS
Grant: T32 HL125247
Pfizer
National Institutes of Health
National Heart, Lung, and Blood Institute
Merck
MeSH Terms
Keywords